1. Home
  2. MRVI vs BIOX Comparison

MRVI vs BIOX Comparison

Compare MRVI & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • BIOX
  • Stock Information
  • Founded
  • MRVI 2014
  • BIOX 2001
  • Country
  • MRVI United States
  • BIOX Argentina
  • Employees
  • MRVI 560
  • BIOX N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • BIOX Agricultural Chemicals
  • Sector
  • MRVI Health Care
  • BIOX Industrials
  • Exchange
  • MRVI Nasdaq
  • BIOX Nasdaq
  • Market Cap
  • MRVI 350.1M
  • BIOX 168.3M
  • IPO Year
  • MRVI 2020
  • BIOX N/A
  • Fundamental
  • Price
  • MRVI $2.42
  • BIOX $2.77
  • Analyst Decision
  • MRVI Hold
  • BIOX Strong Buy
  • Analyst Count
  • MRVI 10
  • BIOX 4
  • Target Price
  • MRVI $5.84
  • BIOX $8.38
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • BIOX 279.5K
  • Earning Date
  • MRVI 08-11-2025
  • BIOX 09-08-2025
  • Dividend Yield
  • MRVI N/A
  • BIOX N/A
  • EPS Growth
  • MRVI N/A
  • BIOX N/A
  • EPS
  • MRVI N/A
  • BIOX N/A
  • Revenue
  • MRVI $219,830,000.00
  • BIOX $383,289,394.00
  • Revenue This Year
  • MRVI N/A
  • BIOX N/A
  • Revenue Next Year
  • MRVI $7.23
  • BIOX $7.30
  • P/E Ratio
  • MRVI N/A
  • BIOX N/A
  • Revenue Growth
  • MRVI N/A
  • BIOX N/A
  • 52 Week Low
  • MRVI $1.67
  • BIOX $2.60
  • 52 Week High
  • MRVI $9.60
  • BIOX $11.39
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • BIOX 35.91
  • Support Level
  • MRVI $2.28
  • BIOX $2.63
  • Resistance Level
  • MRVI $2.47
  • BIOX $2.89
  • Average True Range (ATR)
  • MRVI 0.14
  • BIOX 0.19
  • MACD
  • MRVI -0.01
  • BIOX 0.02
  • Stochastic Oscillator
  • MRVI 27.45
  • BIOX 30.77

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Share on Social Networks: